Crystal Structure
Crystallisation Method: X-ray
Corresponding Chain: A
Sequence Length: 622-689
Detail: Struture Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0481 | ||||
| Gene Name | SLC9A1 | ||||
| Protein Name | Sodium/hydrogen exchanger 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Crystal Structure Crystallisation Method: X-ray Corresponding Chain: A Sequence Length: 622-689 Detail: Struture Info |
||||
| Synonyms | APNH; APNH1; LIKNS; NHE-1; NHE1; Na(+)/H(+) antiporter, amiloride-sensitive; Na(+)/H(+) exchanger 1; PPP1R143; SLC9A1; Solute carrier family 9 member 1 | ||||
| DT Family | Monovalent Cation:Proton Antiporter-1 (CPA1) family ; | ||||
| Tissue Specificity | Kidney and intestine. | ||||
| Function | This transporter mediates and participates in regulating pH value to eliminate acids generated by active metabolism or to combat adverse environmental conditions. | ||||
| Endogenous Substrate(s) | Na+; H+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.